This review aims to synthesize the role of ATF4 in metabolic dysfunction, neurodegenerative diseases, and ocular pathology; the mechanisms underlying its protective versus pathologic effects; and future directions to refine ATF4's potential as a clinical therapeutic target across different diseases. The gene discussed is ATF4; the disease is neurodegenerative disease.